Cancer risk in heterozygotes for ataxia-telangiectasia

International Journal of Cancer

Volumn 93, Issue 2, 2001, Pages 288-293

  Geoffroy Perez, Béatrice ^a   Janin, Nicolas ^a   Ossian, Katia ^b   Laugé, Anthony ^c   Croquette, Marie Françoise ^d   Griscelli, Claude ^a   Debré, Marianne ^a   Bressac de Paillerets, Brigitte ^b   Aurias, Alain ^c   Stoppa Lyonnet, Dominique ^d   Andrieu, Nadine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c Centre Hospitalier Feron Vrau   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Ataxia telangiectasia; Breast cancer; Cancer risk; Family study; Heterozygosity

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; CHROMOSOME SEGREGATION; DNA-BINDING PROTEINS; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HUMANS; MALE; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0035879874     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1329     Document Type: Article

References (37)

1. Ataxia-telangiectasia genes and predisportion lo leukemia, lymphoma and breast cancer
2. Cancer risk and the ATM gene: A continuing debate
3. Breast and other cancers in families with ataxia-telangiectasia
4. Incidence of cancer in 161 families affected by ataxia-telangiectasia
5. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain
6. Cancers in 44 families with ataxia-telangiectasia
7. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia
8. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer
9. ATM mutations and phenotypes in ataxia-telangiectasia families in the British isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
10. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: Haplotype study in French AT families
11. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
12. Mortality rates among carriers of ataxia-telangiectasia mutant alleles
13. Cancer risks in A-T heterozygotes
14. The ATM gene and breast cancer: Is it really a risk factor?
15. Malignant neoplasms in the families of patients with ataxia-telangiectasia
16. The incidence and gene frequency of ataxia-telangiectasia in the United States
17. A single ataxia telangiectasia gene with a product similar to PI-3 kinase
18. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder
19. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23
20. Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM
21. Cohort study analysis with a FORTRAN computer program
22. The design and analysis of cohort studies
23. Cancer predisposition of ataxia-telangiectasia heterozygotes
24. Heterozygous ATM mutations do not contribute to early onset of breast cancer
25. ATM-heterozygous germline mutations contribute to breast cancer susceptibility
26. Underreporting of family history of colon cancer: Correlates and implications
27. How accurate is self-reported family history of colorectal cancer?
28. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia
29. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia
30. Inactivation of the ATM gene in T-cell prolymphocytic leukemias
31. No germline ATM mutation in a series of 1 6T-cell prolymphocytic leukemias
32. Estimates of the worldwide incidence of eighteen major cancers in 1985
33. In search of the tumor-suppressor functions of BRCA1 and BRCA2
34. Exposure, susceptibility and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/white differences, in breast cancer incidence